相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
Alireza Atri et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Increased Cerebral Metabolism After 1 Year of Deep Brain Stimulation in Alzheimer Disease
Gwenn S. Smith et al.
ARCHIVES OF NEUROLOGY (2012)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Gantenerumab for the treatment of Alzheimer's disease
Julien Delrieu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease
Bruno P. Imbimbo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
Semagacestat Pharmacokinetics Are Not Significantly Affected by Formulation, Food, or Time of Dosing in Healthy Participants
Brian A. Willis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ1-42-induced cognitive dysfunction in mice
Se Jin Park et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
Aβ1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
Sun-Young Kook et al.
JOURNAL OF NEUROSCIENCE (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
Regulatory Review of Novel Therapeutics - Comparison of Three Regulatory Agencies
Nicholas S. Downing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Amyloid-β Contributes to Blood-Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
Anika M. S. Hartz et al.
STROKE (2012)
PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
Marwan N. Sabbagh et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)
Amyloid Beta Induces Oxidative Stress-Mediated Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy
Anna Carrano et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Tau as a Therapeutic Target for Alzheimer's Disease
A. Boutajangout et al.
CURRENT ALZHEIMER RESEARCH (2011)
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin
X. A. Alvarez et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2011)
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
Francois Piette et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease A Randomized Trial
Joseph F. Quinn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial
Steven T. DeKosky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais et al.
NEUROBIOLOGY OF AGING (2007)
Immunotherapy for Alzheimer's disease
DS Gelinas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets
G Evin et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Alzheimer disease in the US population - Prevalence estimates using the 2000 census
LE Hebert et al.
ARCHIVES OF NEUROLOGY (2003)
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
JL Eriksen et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease
C Hock et al.
NEURON (2003)
Astrocytic expression of the Alzheimer's disease β-secretase (BACE1) is stimulus-dependent
M Hartlage-Rübsamen et al.
GLIA (2003)
Transcriptional activation and increase in expression of Alzheimer's β-amyloid precursor protein gene is mediated by TGF-β in normal human astrocytes
T Burton et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
